Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cognitive ontologies for neuropsychiatric phenomics research.
Bilder RM, Sabb FW, Parker DS, Kalar D, Chu WW, Fox J, Freimer NB, Poldrack RA. Bilder RM, et al. Among authors: fox j. Cogn Neuropsychiatry. 2009;14(4-5):419-50. doi: 10.1080/13546800902787180. Cogn Neuropsychiatry. 2009. PMID: 19634038 Free PMC article. Review.
Training the next generation of quality improvement champions in pediatric urology: A virtual program co-sponsored by the journal of pediatric urology.
Ellison JS, Aziz K, Amar S, Cannon S, Chan YY, Fox JA, Hannick JH, Kisa P, O'Toole S, Waterschoot M, Yadav P, Koyle M. Ellison JS, et al. Among authors: fox ja. J Pediatr Urol. 2024 May 23:S1477-5131(24)00276-6. doi: 10.1016/j.jpurol.2024.04.024. Online ahead of print. J Pediatr Urol. 2024. PMID: 38839477 No abstract available.
Advancing Transthyretin Amyloidosis Drug Development in an Evolving Treatment Landscape: Amyloidosis Forum Meeting Proceedings.
Maurer MS, Soman P, Hernandez A, Garcia-Pavia P, Signorovitch J, Wei LJ, Hanna M, Ruberg FL, Kittleson M, Kazi D, Dorbala S, Hsu K, Lousada I, Adigun R, Dunnmon P, Kelly J, Gillmore J; Amyloidosis Forum Meeting Panelists. Maurer MS, et al. Adv Ther. 2024 Jun 4. doi: 10.1007/s12325-024-02891-0. Online ahead of print. Adv Ther. 2024. PMID: 38833142 Review.
MAVMET trial: maraviroc and/or metformin for metabolic dysfunction-associated fatty liver disease(MAFLD) in adults with suppressed HIV.
Mccabe L, Burns JE, Latifoltojar A, Post FA, Fox J, Pool E, Waters A, Santana B, Garvey L, Johnson M, Mcguinness I, Chouhan M, Edwards J, Goodman AL, Cooke G, Murphy C, Collaco-Moraes Y, Webb H, Gregory A, Mohamed F, Rauchenberger M, Ryder SD, Sandford C, Baker JV, Angus B, Boesecke C, Orkin C, Punwani S, Clark A, Gilson R, Dunn D, Pett SL; MAVMET Study group. Mccabe L, et al. Among authors: fox j. AIDS. 2024 May 31. doi: 10.1097/QAD.0000000000003947. Online ahead of print. AIDS. 2024. PMID: 38819839
5,679 results